Corral I, Quereda C, Dronda F, Navas E, Hermida JM, Moreno C, Martínez-San-Millán J.

Progressive multifocal leukoencephalopathy mimicking milliary CNS tuberculosis

JOURNAL OF NEUROVIROLOGY 2015. 21(6, SI): 691-693. Nº de citas: 1

[doi:10.1007/s13365-015-0367-6]

Martínez-Bonet M, Isabel Clemente M, Jesús Serramía M, Muñoz E, Moreno S, Ángeles Muñoz-Fernández M.

Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1

SCIENTIFIC REPORTS 2015. 5: 16445-16445. Nº de citas: 31

[doi:10.1038/srep16445]

Casado JL, Bañón S.

Dutrebis (lamivudine and raltegravir) for use in combination with other antiretroviral products for the treatment of HIV-1 infection

EXPERT REVIEW OF CLINICAL PHARMACOLOGY 2015. 8(6): 709-718. Nº de citas: 4

[doi:10.1586/17512433.2015.1090873]

Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, De Wit S, Richert L, Babiker A, Buño A, Castagna A, Girard PM, Chene G, Raffi F, Arribas JR, NEAT001/ANRS143 Study Group.

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

The lancet. HIV 2015. 2(11): 464-473. Nº de citas: 65

[doi:10.1016/S2352-3018(15)00181-2]

Parrondo J, Moreno S, Losa JE, Berenguer J, Martinez-Sesmero JM, Grasset E, Cenoz-Gomis S.

Cost-Utility Analysis of Dolutegravir/Abacavir/Lamivudine (Dtg/Abc/3tc) as a Single Tablet Treatment of Naïve Hiv Infected Patientss.

VALUE IN HEALTH 2015. 18(7): . Nº de citas: 1

[doi:10.1016/j.jval.2015.09.1507]

Rubio-Terrés C, Cobo Reinoso J, Grau Cerrato S, Mensa Pueyo J, Salavert Lletí M, Toledo A, Anguita P, Rubio-Rodríguez D, Watt M, Gani R.

Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 2015. 34(11): 2213-2223. Nº de citas: 21

[doi:10.1007/s10096-015-2472-0]

Santos JR, Blanco JL, Masiá M, Gutiérrez F, Pérez-Elías MJ, Iribarren JA, Force L, Antela A, Knobel H, Salavert M, López Bernaldo De Quirós JC, Pino M, Paredes R, Clotet B.

Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences

The Journal of antimicrobial chemotherapy 2015. 70(11): 3087-3095. Nº de citas: 9

[doi:10.1093/jac/dkv205]

Pérez-Romero P, Bulnes-Ramos A, Torre-Cisneros J, Gavaldá J, Aydillo TA, Moreno A, Montejo M, Fariñas MC, Carratalá J, Muñoz P, Blanes M, Fortún J, Suárez-Benjumea A, López-Medrano F, Barranco JL, Peghin M, Roca C, Lara R, Cordero E, Influenza Vaccine in Solid Organ Transplant Recipient Study Group, Spanish Netwo.

Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2015. 21(11): . Nº de citas: 22

[doi:10.1016/j.cmi.2015.07.014]

Martínez-Bonet M, Clemente MI, Álvarez S, Díaz L, García-Alonso D, Muñoz E, Moreno S, Muñoz-Fernández MÁ.

Antiretroviral drugs do not interfere with bryostatin-mediated HIV-1 latency reversal

ANTIVIRAL RESEARCH 2015. 123: 163-171. Nº de citas: 9

[doi:10.1016/j.antiviral.2015.09.014]

Pérez-Molina JA, Perez AM, Norman FF, Monge-Maillo B, López-Vélez R.

Old and new challenges in Chagas disease

LANCET INFECTIOUS DISEASES 2015. 15(11): 1347-1356. Nº de citas: 60

[doi:10.1016/S1473-3099(15)00243-1]

San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martín-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM, REIPI Network, Spain.

Effect of delaying prophylaxis against CMV in D plus /R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease

JOURNAL OF INFECTION 2015. 71(5): 561-570. Nº de citas: 8

[doi:10.1016/j.jinf.2015.06.013]

Casado JL, Esteban MA, Bañón S, Moreno A, Perez-Elías MJ, Mateos ML, Moreno S, Quereda C.

Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response

DIGESTIVE DISEASES AND SCIENCES 2015. 60(11): 3473-3481. Nº de citas: 11

[doi:10.1007/s10620-015-3773-y]

Cuervo G, Camoez M, Shaw E, Dominguez MÁ, Gasch O, Padilla B, Pintado V, Almirante B, Molina J, López-Medrano F, Ruiz de Gopegui E, Martinez JA, Bereciartua E, Rodriguez-Lopez F, Fernandez-Mazarrasa C, Goenaga MÁ, Benito N, Rodriguez-Baño J, Espejo E, Pujol M.

Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients

BMC INFECTIOUS DISEASES 2015. 15(1): 484-484. Nº de citas: 3

[doi:10.1186/s12879-015-1227-y]

Palladino C, Gómez ML, Soler-Palacín P, González-Tomé MI, De Ory SJ, Espiau M, Hoyos SP, León-Leal JA, Méndez M, Moreno-Pérez D, Guasch CF, Sierra AM, Guruceta IP, Guillén SM, Briz V.

Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice

AIDS 2015. 29(16): 2155-2159. Nº de citas: 3

[doi:10.1097/QAD.0000000000000819]

Treviño A, Caballero E, de Mendoza C, Aguilera A, Pirón M, Soriano V.

The Burden of Neglected HIV-2 and HTLV-1 Infections in Spain

AIDS REVIEWS 2015. 17(4): 212-219. Nº de citas: 10

Muñoz P, Kestler M, De Alarcon A, Miro JM, Bermejo J, Rodríguez-Abella H, Fariñas MC, Cobo Belaustegui M, Mestres C, Llinares P, Goenaga M, Navas E, Oteo JA, Tarabini P, Bouza E.

Current Epidemiology and Outcome of Infective Endocarditis A Multicenter, Prospective, Cohort Study

Medicine 2015. 94(43): . Nº de citas: 76

[doi:10.1097/MD.0000000000001816]

Navas E, Torner N, Broner S, Godoy P, Martínez A, Bartolomé R, Domínguez A.

Economic costs of outbreaks of acute viral gastroenteritis due to norovirus in Catalonia (Spain), 2010-2011

Bmc Public Health 2015. 15(1): 999-999. Nº de citas: 13

[doi:10.1186/s12889-015-2289-x]

García Comas L, Ordobás Gavín M, Sanz Moreno JC, Ramos Blázquez B, Gutiérrez Rodríguez A, Astray Mochales J, Moreno Guillén S.

Prevalence of hepatitis C antibodies in the population aged 16-80 years in the Community of Madrid 2008-2009.

JOURNAL OF MEDICAL VIROLOGY 2015. 87(10): 1697-1701. Nº de citas: 22

[doi:10.1002/jmv.24219]